Company Filing History:
Years Active: 2003
Title: Edwin Chan: Innovator in Hepatic Treatment
Introduction
Edwin Chan is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of hepatic conditions. His innovative work focuses on the development of adenosine A2A receptor antagonists, which have the potential to treat and prevent hepatic fibrosis, cirrhosis, and fatty liver.
Latest Patents
Edwin Chan holds a patent for "Adenosine A2A receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver." This patent outlines a method for preventing and treating hepatic cirrhosis, fibrosis, and fatty liver by administering an effective amount of at least one adenosine A receptor antagonist or at least one adenosine uptake promoter to a subject in need.
Career Highlights
Chan is affiliated with New York University, where he continues to advance his research and innovation in the medical field. His work has the potential to significantly impact the treatment of liver diseases, providing new avenues for patient care.
Collaborations
Edwin Chan collaborates with Bruce N Cronstein, a fellow researcher, to further explore the implications of his findings and enhance the development of effective treatments for hepatic conditions.
Conclusion
Edwin Chan's contributions to the field of medicine through his innovative patent demonstrate his commitment to improving health outcomes for individuals suffering from liver diseases. His work exemplifies the importance of research and innovation in the medical field.